Here's the live share price of Emcure Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Emcure Pharmaceuticals has declined 0.14% CAGR. Over the past year, the corresponding return has been -9.50%.
Emcure Pharmaceuticals’s current P/E of 34.42x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Emcure Pharmaceuticals | -0.79 | -7.06 | 1.78 | 45.65 | -9.42 | -0.14 | -0.08 |
Sun Pharmaceutical Industries | 1.22 | -1.18 | -2.17 | -5.45 | -13.55 | 22.62 | 25.80 |
Divi's Laboratories | 1.07 | -1.16 | -6.76 | 7.50 | 11.74 | 19.00 | 13.69 |
Cipla | -0.57 | -0.61 | 3.41 | 4.14 | -6.96 | 14.54 | 15.64 |
Torrent Pharmaceuticals | -1.55 | -3.17 | 8.77 | 15.60 | 2.48 | 33.72 | 20.04 |
Dr. Reddy's Laboratories | 0.77 | 3.98 | -0.36 | 14.23 | -0.90 | 17.04 | 6.37 |
Mankind Pharma | -1.34 | 4.20 | 9.41 | 18.49 | 4.90 | 21.81 | 12.57 |
Zydus Lifesciences | -0.45 | 4.88 | 7.90 | 15.82 | -6.82 | 42.14 | 21.25 |
Lupin | 3.06 | 3.49 | 4.88 | 2.37 | -10.24 | 47.01 | 14.45 |
Abbott India | -0.22 | -4.30 | -1.82 | 3.49 | 8.15 | 21.55 | 13.69 |
Alkem Laboratories | 3.64 | 3.09 | 14.57 | 14.48 | -11.35 | 19.31 | 14.19 |
Aurobindo Pharma | 4.70 | 0.89 | -0.88 | -1.19 | -29.15 | 28.29 | 6.23 |
Glenmark Pharmaceuticals | -3.00 | 4.72 | 25.02 | 44.48 | 20.67 | 77.41 | 33.26 |
Laurus Labs | 0.41 | 4.05 | 36.30 | 54.85 | 79.61 | 21.02 | 26.19 |
Biocon | -0.85 | -0.92 | 2.35 | 8.07 | -3.90 | 7.54 | -3.99 |
Anthem Biosciences | 3.30 | 5.21 | 15.35 | 15.35 | 15.35 | 4.91 | 2.92 |
GlaxoSmithKline Pharmaceuticals | -2.98 | -1.44 | -15.47 | 2.11 | -1.81 | 24.83 | 9.26 |
Cohance Lifesciences | 0.03 | 10.13 | -0.25 | -12.83 | -14.33 | 29.12 | 20.87 |
Ipca Laboratories | 0.58 | -4.56 | -2.61 | 0.46 | -9.27 | 15.52 | 4.25 |
Gland Pharma | 6.52 | 2.83 | 16.06 | 30.53 | 9.76 | -3.30 | 2.20 |
Over the last one year, Emcure Pharmaceuticals has declined 9.42% compared to peers like Sun Pharmaceutical Industries (-13.55%), Divi's Laboratories (11.74%), Cipla (-6.96%). From a 5 year perspective, Emcure Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.80%) and Divi's Laboratories (13.69%).
Day | SMA | EMA |
---|---|---|
5 | 1,370.35 | 1,360.62 |
10 | 1,372.92 | 1,372.41 |
20 | 1,420.77 | 1,388.3 |
50 | 1,385.21 | 1,375.33 |
100 | 1,297.4 | 1,325.73 |
200 | 1,245.86 | 1,317.26 |
In the latest quarter, Emcure Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 2.84%, FII holding fell to 2.86%, and public shareholding moved up to 16.39% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Aditya Birla Sun Life ELSS Tax Saver Fund | 10,55,602 | 0.97 | 147.09 |
Nippon India Multi Cap Fund | 10,00,000 | 0.3 | 139.34 |
Nippon India Pharma Fund | 4,70,272 | 0.78 | 65.53 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 4,45,701 | 1.01 | 62.1 |
Aditya Birla Sun Life Multi-Cap Fund | 4,39,742 | 0.96 | 61.27 |
DSP Healthcare Fund | 3,93,289 | 1.76 | 54.8 |
DSP Equity & Bond Fund | 3,59,109 | 0.44 | 50.04 |
Aditya Birla Sun Life Large and Mid Cap Fund | 2,75,555 | 0.68 | 38.4 |
Bandhan Small Cap Fund | 2,62,129 | 0.25 | 36.53 |
DSP Top 100 Equity Fund | 2,21,977 | 0.48 | 30.93 |
Date Time | Announcement |
---|---|
Aug 30, 2025, 1:59 AM IST | Emcure Pharmaceutica - Update On Re-Appointment Of Dr. Mukund Gurjar As A Whole-Time Director And Appointment Of Secretarial |
Aug 30, 2025, 1:50 AM IST | Emcure Pharmaceutica - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 28, 2025, 11:20 PM IST | Emcure Pharmaceutica - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Aug 13, 2025, 9:26 PM IST | Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Aug 08, 2025, 3:20 AM IST | Emcure Pharmaceutica - Intimation Under Regulation 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requiremen |
Emcure Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4381.92 Cr. and Equity Capital is Rs. 189.48 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Emcure Pharmaceuticals is ₹1,349.60 as on Sep 17, 2025.
The Emcure Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Emcure Pharmaceuticals is ₹25,618.69 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Emcure Pharmaceuticals are ₹1,365.00 and ₹1,348.65.
The 52-week high/low is the highest and lowest price at which Emcure Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Emcure Pharmaceuticals is ₹1,577.50 and 52-week low of Emcure Pharmaceuticals is ₹890.00 as on Sep 17, 2025.
The Emcure Pharmaceuticals has shown returns of -0.82% over the past day, -7.15% for the past month, 1.69% over 3 months, -9.5% over 1 year, -0.23% across 3 years, and -0.14% over 5 years.
P/E ratio of and PB ratio of Emcure Pharmaceuticals are 34.42 and 6.22 on Sep 17, 2025. While the company gives a dividend yield of 0.22 per annum.